| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C13H18Cl2N2O2
|
|---|
| Exact mass |
304.0745
|
|---|
| Mol weight |
305.2002
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Pathway |
| map05204 | Chemical carcinogenesis - DNA adducts |
|
|---|
| Network |
nt06250 DNA adduct formation (cancer) |
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AA Nitrogen mustard analogues
L01AA03 Melphalan
D00369 Melphalan (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Alkylating Agents
Melphalan
D00369 Melphalan (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
421 Alkylating agents
4219 Others
D00369 Melphalan (JP18/USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01678 Nitrogen mustard analog
DG00676 Melphalan
D00369 Melphalan
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00369 Melphalan
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 19
1 C8y C 24.0482 -21.2668
2 N1c N 25.2586 -21.9594
3 C8x C 22.8380 -21.9594
4 C8x C 24.0482 -19.8646
5 C1b C 25.2586 -23.3617
6 C1b C 26.4748 -21.2668
7 C8x C 21.6218 -21.2668
8 C8x C 22.8380 -19.1605
9 C8y C 21.6277 -19.8762
10 C1b C 20.4173 -19.1722
11 C1c C 19.2071 -19.8762
12 C6a C 17.9909 -19.1722
13 N1a N 19.2071 -21.2728
14 O6a O 16.7864 -19.8762
15 O6a O 17.9909 -17.7698
16 C1b C 26.4780 -19.8928
17 X Cl 27.7033 -19.1889
18 C1b C 24.0285 -24.0717
19 X Cl 24.0281 -25.4753
BOND 19
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 2
8 7 9 2
9 9 10 1
10 10 11 1
11 11 12 1
12 11 13 1 #Down
13 12 14 1
14 12 15 2
15 8 9 1
16 6 16 1
17 16 17 1
18 5 18 1
19 18 19 1
|
|---|
